Cargando…
Angiotensin converting enzyme inhibitors remain the first treatment of choice
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association of Internal Medicine
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773733/ https://www.ncbi.nlm.nih.gov/pubmed/26932400 http://dx.doi.org/10.3904/kjim.2016.026 |
| _version_ | 1782418795697012736 |
|---|---|
| author | Oh, Pyung Chun Sakuma, Ichiro Hayashi, Toshio Koh, Kwang Kon |
| author_facet | Oh, Pyung Chun Sakuma, Ichiro Hayashi, Toshio Koh, Kwang Kon |
| author_sort | Oh, Pyung Chun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4773733 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | The Korean Association of Internal Medicine |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47737332016-03-03 Angiotensin converting enzyme inhibitors remain the first treatment of choice Oh, Pyung Chun Sakuma, Ichiro Hayashi, Toshio Koh, Kwang Kon Korean J Intern Med Editorial The Korean Association of Internal Medicine 2016-03 2016-02-26 /pmc/articles/PMC4773733/ /pubmed/26932400 http://dx.doi.org/10.3904/kjim.2016.026 Text en Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Oh, Pyung Chun Sakuma, Ichiro Hayashi, Toshio Koh, Kwang Kon Angiotensin converting enzyme inhibitors remain the first treatment of choice |
| title | Angiotensin converting enzyme inhibitors remain the first treatment of choice |
| title_full | Angiotensin converting enzyme inhibitors remain the first treatment of choice |
| title_fullStr | Angiotensin converting enzyme inhibitors remain the first treatment of choice |
| title_full_unstemmed | Angiotensin converting enzyme inhibitors remain the first treatment of choice |
| title_short | Angiotensin converting enzyme inhibitors remain the first treatment of choice |
| title_sort | angiotensin converting enzyme inhibitors remain the first treatment of choice |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773733/ https://www.ncbi.nlm.nih.gov/pubmed/26932400 http://dx.doi.org/10.3904/kjim.2016.026 |
| work_keys_str_mv | AT ohpyungchun angiotensinconvertingenzymeinhibitorsremainthefirsttreatmentofchoice AT sakumaichiro angiotensinconvertingenzymeinhibitorsremainthefirsttreatmentofchoice AT hayashitoshio angiotensinconvertingenzymeinhibitorsremainthefirsttreatmentofchoice AT kohkwangkon angiotensinconvertingenzymeinhibitorsremainthefirsttreatmentofchoice |